Chemicals - Specialty
Compare Stocks
5 / 10Stock Comparison
BCPC vs INGR vs IFF vs ADM vs BG
Revenue, margins, valuation, and 5-year total return — side by side.
Packaged Foods
Chemicals - Specialty
Agricultural Farm Products
Agricultural Farm Products
BCPC vs INGR vs IFF vs ADM vs BG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Chemicals - Specialty | Packaged Foods | Chemicals - Specialty | Agricultural Farm Products | Agricultural Farm Products |
| Market Cap | $5.16B | $6.77B | $20.70B | $37.42B | $24.24B |
| Revenue (TTM) | $1.06B | $7.22B | $10.79B | $80.61B | $80.54B |
| Net Income (TTM) | $158M | $729M | $839M | $1.08B | $686M |
| Gross Margin | 36.3% | 25.3% | 35.1% | 5.8% | 5.2% |
| Operating Margin | 21.0% | 14.1% | 8.0% | 1.5% | 2.4% |
| Forward P/E | 30.7x | 9.9x | 18.1x | 17.2x | 13.9x |
| Total Debt | $192M | $1.79B | $6.65B | $8.41B | $16.95B |
| Cash & Equiv. | $75M | $1.03B | $590M | $1.01B | $1.14B |
BCPC vs INGR vs IFF vs ADM vs BG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Balchem Corporation (BCPC) | 100 | 159.9 | +59.9% |
| Ingredion Incorpora… (INGR) | 100 | 127.5 | +27.5% |
| International Flavo… (IFF) | 100 | 60.9 | -39.1% |
| Archer-Daniels-Midl… (ADM) | 100 | 197.6 | +97.6% |
| Bunge Global S.A. (BG) | 100 | 320.2 | +220.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BCPC vs INGR vs IFF vs ADM vs BG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BCPC ranks third and is worth considering specifically for growth exposure.
- Rev growth 8.8%, EPS growth 20.9%, 3Y rev CAGR 3.2%
- 15.0% margin vs BG's 0.9%
INGR carries the broadest edge in this set and is the clearest fit for valuation efficiency.
- PEG 0.59 vs BCPC's 2.40
- Lower P/E (9.9x vs 13.9x)
- 3.0% yield, 3-year raise streak, vs ADM's 2.6%
- 9.4% ROA vs BG's 1.6%, ROIC 15.5% vs 3.3%
Among these 5 stocks, IFF doesn't own a clear edge in any measured category.
ADM is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 31 yrs, beta 0.12, yield 2.6%
- 147.7% 10Y total return vs BCPC's 162.9%
- Lower volatility, beta 0.12, Low D/E 36.5%, current ratio 11.20x
- Beta 0.12, yield 2.6%, current ratio 11.20x
BG is the #2 pick in this set and the best alternative if growth and momentum is your priority.
- 32.4% revenue growth vs ADM's -6.2%
- +67.5% vs INGR's -19.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 32.4% revenue growth vs ADM's -6.2% | |
| Value | Lower P/E (9.9x vs 13.9x) | |
| Quality / Margins | 15.0% margin vs BG's 0.9% | |
| Stability / Safety | Beta 0.12 vs IFF's 0.86, lower leverage | |
| Dividends | 3.0% yield, 3-year raise streak, vs ADM's 2.6% | |
| Momentum (1Y) | +67.5% vs INGR's -19.4% | |
| Efficiency (ROA) | 9.4% ROA vs BG's 1.6%, ROIC 15.5% vs 3.3% |
BCPC vs INGR vs IFF vs ADM vs BG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
BCPC vs INGR vs IFF vs ADM vs BG — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
INGR leads in 2 of 6 categories
BCPC leads 1 • BG leads 1 • IFF leads 0 • ADM leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
BCPC leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ADM is the larger business by revenue, generating $80.6B annually — 76.2x BCPC's $1.1B. BCPC is the more profitable business, keeping 15.0% of every revenue dollar as net income compared to BG's 0.9%. On growth, BG holds the edge at +87.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.1B | $7.2B | $10.8B | $80.6B | $80.5B |
| EBITDAEarnings before interest/tax | $267M | $1.2B | $1.7B | $3.0B | $2.8B |
| Net IncomeAfter-tax profit | $158M | $729M | $839M | $1.1B | $686M |
| Free Cash FlowCash after capex | $182M | $809M | $400M | $4.8B | $112M |
| Gross MarginGross profit ÷ Revenue | +36.3% | +25.3% | +35.1% | +5.8% | +5.2% |
| Operating MarginEBIT ÷ Revenue | +21.0% | +14.1% | +8.0% | +1.5% | +2.4% |
| Net MarginNet income ÷ Revenue | +15.0% | +10.1% | +7.8% | +1.3% | +0.9% |
| FCF MarginFCF ÷ Revenue | +17.2% | +11.2% | +3.7% | +6.0% | +0.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +8.1% | -2.4% | -3.6% | +1.6% | +87.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +10.6% | +79.0% | +116.6% | +1.6% | -76.4% |
Valuation Metrics
INGR leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 9.6x trailing earnings, INGR trades at a 72% valuation discount to ADM's 34.8x P/E. Adjusting for growth (PEG ratio), INGR offers better value at 0.57x vs BCPC's 2.65x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $5.2B | $6.8B | $20.7B | $37.4B | $24.2B |
| Enterprise ValueMkt cap + debt − cash | $5.3B | $7.5B | $26.8B | $44.8B | $40.1B |
| Trailing P/EPrice ÷ TTM EPS | 33.89x | 9.61x | -55.51x | 34.83x | 25.39x |
| Forward P/EPrice ÷ next-FY EPS est. | 30.74x | 9.91x | 18.13x | 17.24x | 13.90x |
| PEG RatioP/E ÷ EPS growth rate | 2.65x | 0.57x | — | — | — |
| EV / EBITDAEnterprise value multiple | 20.01x | 5.98x | 13.64x | 17.20x | 22.72x |
| Price / SalesMarket cap ÷ Revenue | 4.97x | 0.94x | 1.90x | 0.47x | 0.34x |
| Price / BookPrice ÷ Book value/share | 4.17x | 1.60x | 1.46x | 1.63x | 1.19x |
| Price / FCFMarket cap ÷ FCF | 29.79x | 13.25x | 80.87x | 8.90x | — |
Profitability & Efficiency
INGR leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
INGR delivers a 17.1% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $4 for BG. BCPC carries lower financial leverage with a 0.15x debt-to-equity ratio, signaling a more conservative balance sheet compared to BG's 0.97x. On the Piotroski fundamental quality scale (0–9), BCPC scores 9/9 vs BG's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +12.4% | +17.1% | +5.9% | +4.7% | +4.3% |
| ROA (TTM)Return on assets | +9.4% | +9.4% | +3.3% | +2.2% | +1.6% |
| ROICReturn on invested capital | +12.2% | +15.5% | +3.5% | +3.3% | +3.3% |
| ROCEReturn on capital employed | +14.8% | +16.3% | +4.4% | +4.2% | +4.5% |
| Piotroski ScoreFundamental quality 0–9 | 9 | 8 | 5 | 6 | 2 |
| Debt / EquityFinancial leverage | 0.15x | 0.41x | 0.47x | 0.37x | 0.97x |
| Net DebtTotal debt minus cash | $117M | $760M | $6.1B | $7.4B | $15.8B |
| Cash & Equiv.Liquid assets | $75M | $1.0B | $590M | $1.0B | $1.1B |
| Total DebtShort + long-term debt | $192M | $1.8B | $6.7B | $8.4B | $17.0B |
| Interest CoverageEBIT ÷ Interest expense | 15.23x | 27.32x | 5.26x | 3.03x | 3.10x |
Total Returns (Dividends Reinvested)
BG leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BG five years ago would be worth $15,192 today (with dividends reinvested), compared to $6,548 for IFF. Over the past 12 months, BG leads with a +67.5% total return vs INGR's -19.4%. The 3-year compound annual growth rate (CAGR) favors BG at 13.8% vs IFF's -3.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +4.5% | -0.7% | +19.7% | +32.4% | +35.6% |
| 1-Year ReturnPast 12 months | -2.0% | -19.4% | +11.6% | +67.1% | +67.5% |
| 3-Year ReturnCumulative with dividends | +27.7% | +7.8% | -10.4% | +10.8% | +47.5% |
| 5-Year ReturnCumulative with dividends | +27.4% | +28.2% | -34.5% | +28.2% | +51.9% |
| 10-Year ReturnCumulative with dividends | +162.9% | +13.5% | -10.3% | +147.7% | +142.2% |
| CAGR (3Y)Annualised 3-year return | +8.5% | +2.5% | -3.6% | +3.5% | +13.8% |
Risk & Volatility
Evenly matched — IFF and ADM each lead in 1 of 2 comparable metrics.
Risk & Volatility
ADM is the less volatile stock with a 0.12 beta — it tends to amplify market swings less than IFF's 0.86 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IFF currently trades 96.3% from its 52-week high vs INGR's 75.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.31x | 0.27x | 0.86x | 0.12x | 0.22x |
| 52-Week HighHighest price in past year | $183.90 | $141.78 | $84.19 | $81.75 | $133.93 |
| 52-Week LowLowest price in past year | $139.17 | $100.71 | $59.14 | $46.81 | $71.60 |
| % of 52W HighCurrent price vs 52-week peak | +87.5% | +75.7% | +96.3% | +95.0% | +93.3% |
| RSI (14)Momentum oscillator 0–100 | 30.6 | 33.3 | 60.5 | 66.3 | 47.7 |
| Avg Volume (50D)Average daily shares traded | 189K | 588K | 1.6M | 3.8M | 1.7M |
Analyst Outlook
Evenly matched — INGR and ADM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BCPC as "Buy", INGR as "Hold", IFF as "Buy", ADM as "Hold", BG as "Buy". Consensus price targets imply 8.9% upside for INGR (target: $117) vs -4.7% for ADM (target: $74). For income investors, INGR offers the higher dividend yield at 3.01% vs BCPC's 0.54%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $162.00 | $117.00 | $88.13 | $74.00 | $133.67 |
| # AnalystsCovering analysts | 10 | 21 | 33 | 36 | 25 |
| Dividend YieldAnnual dividend ÷ price | +0.5% | +3.0% | +2.0% | +2.6% | +2.2% |
| Dividend StreakConsecutive years of raises | 11 | 3 | 0 | 31 | 5 |
| Dividend / ShareAnnual DPS | $0.87 | $3.24 | $1.60 | $2.04 | $2.76 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.1% | +3.3% | +0.2% | 0.0% | +2.3% |
INGR leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). BCPC leads in 1 (Income & Cash Flow). 2 tied.
BCPC vs INGR vs IFF vs ADM vs BG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BCPC or INGR or IFF or ADM or BG a better buy right now?
For growth investors, Bunge Global S.
A. (BG) is the stronger pick with 32. 4% revenue growth year-over-year, versus -6. 2% for Archer-Daniels-Midland Company (ADM). Ingredion Incorporated (INGR) offers the better valuation at 9. 6x trailing P/E (9. 9x forward), making it the more compelling value choice. Analysts rate Balchem Corporation (BCPC) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BCPC or INGR or IFF or ADM or BG?
On trailing P/E, Ingredion Incorporated (INGR) is the cheapest at 9.
6x versus Archer-Daniels-Midland Company at 34. 8x. On forward P/E, Ingredion Incorporated is actually cheaper at 9. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Ingredion Incorporated wins at 0. 59x versus Balchem Corporation's 2. 40x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — BCPC or INGR or IFF or ADM or BG?
Over the past 5 years, Bunge Global S.
A. (BG) delivered a total return of +51. 9%, compared to -34. 5% for International Flavors & Fragrances Inc. (IFF). Over 10 years, the gap is even starker: BCPC returned +162. 9% versus IFF's -10. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BCPC or INGR or IFF or ADM or BG?
By beta (market sensitivity over 5 years), Archer-Daniels-Midland Company (ADM) is the lower-risk stock at 0.
12β versus International Flavors & Fragrances Inc. 's 0. 86β — meaning IFF is approximately 608% more volatile than ADM relative to the S&P 500. On balance sheet safety, Balchem Corporation (BCPC) carries a lower debt/equity ratio of 15% versus 97% for Bunge Global S. A. — giving it more financial flexibility in a downturn.
05Which is growing faster — BCPC or INGR or IFF or ADM or BG?
By revenue growth (latest reported year), Bunge Global S.
A. (BG) is pulling ahead at 32. 4% versus -6. 2% for Archer-Daniels-Midland Company (ADM). On earnings-per-share growth, the picture is similar: Balchem Corporation grew EPS 20. 9% year-over-year, compared to -253. 7% for International Flavors & Fragrances Inc.. Over a 3-year CAGR, BCPC leads at 3. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BCPC or INGR or IFF or ADM or BG?
Balchem Corporation (BCPC) is the more profitable company, earning 14.
9% net margin versus -3. 4% for International Flavors & Fragrances Inc. — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BCPC leads at 21. 1% versus 1. 5% for BG. At the gross margin level — before operating expenses — BCPC leads at 35. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BCPC or INGR or IFF or ADM or BG more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Ingredion Incorporated (INGR) is the more undervalued stock at a PEG of 0. 59x versus Balchem Corporation's 2. 40x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Ingredion Incorporated (INGR) trades at 9. 9x forward P/E versus 30. 7x for Balchem Corporation — 20. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for INGR: 8. 9% to $117. 00.
08Which pays a better dividend — BCPC or INGR or IFF or ADM or BG?
All stocks in this comparison pay dividends.
Ingredion Incorporated (INGR) offers the highest yield at 3. 0%, versus 0. 5% for Balchem Corporation (BCPC).
09Is BCPC or INGR or IFF or ADM or BG better for a retirement portfolio?
For long-horizon retirement investors, Archer-Daniels-Midland Company (ADM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
12), 2. 6% yield, +147. 7% 10Y return). Both have compounded well over 10 years (ADM: +147. 7%, IFF: -10. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BCPC and INGR and IFF and ADM and BG?
These companies operate in different sectors (BCPC (Basic Materials) and INGR (Consumer Defensive) and IFF (Basic Materials) and ADM (Consumer Defensive) and BG (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: BCPC is a small-cap quality compounder stock; INGR is a small-cap deep-value stock; IFF is a mid-cap quality compounder stock; ADM is a mid-cap quality compounder stock; BG is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Consumer Defensive
- Market Cap > $100B
- Revenue Growth > 43%
- Dividend Yield > 0.8%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.